Patient Safety Rule

Disobeying safety rules is not at all like flouting many other rules. You can get seriously hurt. No appeal. No bargaining for another 12 points so you can get into medical school. Perhaps as a patient, but certainly not as a student. So, go ahead. Ignore these guidelines. But remember—... 

Food and Drug Administration (1998) Regulations requiring manufacturers to assess the safety and effectiveness of new drugs and biological products in pediatric patients final rule. Ped Register 63 66631-66672. 

ANVISA is a federal organization linked to Brazil s Health Ministry, which has the incumbency of looking after medication quality and other health products aimed at patients safety. Several documents regarding GMP and quality control are easily accessed. The agency is also responsible for establishing enforcing the rules and can take corrective measures and punish the offenders [46],... 

Therefore pre-marketing trials are limited in information on a drugs full safety profile because they employ too few patients. The "rule of three" slates that to detect an unintended drug effect that occurs with a particular frequency, the number of subjects needed to follow up is 3 times that of the estimated frequency of the event. Consequently if an ADR occurs in 1 in... 

Department of Health and Human Services. Patient safety and quality improvement final rule. 2008. 

Otsuka, Y, Ayzawa, J., Akiyoshi, M, Noguchi, H., Improvement Framework for Safety Rule Using Incident Reporting and Worker s Practical Heuristics (Empirical Gonsideration in Patient Safety Management), Transactions of the Japan Society of Mechanical Engineers, Vol. 74, No. 4,2008, pp. 1012-1019. 

Patient safety has become a key value for our entire organization and the foundation of our operations. Patient safety is everyone s job. High-risk processes and procedures are analyzed to detect vulnerabilities and failure points that could contribute to an accident. Employees are engaged in anticipating where the next failure or accident may occur and are empowered to act in the interest of restoring safety if they perceive that we are moving into conditions of intolerable risk. Local teams operate with simple rules Fix what you can. Tell what you fixed. Find someone to fix what you cannot. ... 

In the language of patient safety, health care workers who provide direct patient care work at what is known as the sharp end (Reason, 1990). This term refers to those points of vulnerability in the care delivery system where expertise is applied, where failure is visible, and accidents are experienced. Work at the sharp end is characterized by management of competing demands for production and for failure-free performance. Professionals at the sharp end are always weighing the probability of various outcomes of their actions successful operations are the rule and failure is rare. 

Be patient with the people enforcing the new safety rules and policies. Others will follow in your footsteps. Take part in activities designed to allow your participation whenever available. 

Inspect all bed frames, side rails, and mattresses as part of the preventive maintenance procedures. Ensure proper bed alignment and that no gap exists wide enough to entrap a patient. Never replace mattresses and side rails with dimensions different than the original equipment supplied by the manufacturer. Check bedside rails for proper installation using manufacturer s instructions. Establish safety rules and procedures for patients considered at high risk for entrapment. Use bedside rail protectors to close off open spaces which could lead to entrapment. Never use bedside rails as a patient protective restraint. Use of restraints requires frequent monitoring and compliance with... 

Upjohn V Finch upholds enforcement of the 1962 drug effectiveness amendments by ruling that commercial success alone does not constitute substantial evidence of drug safety and efficacy. FDA requires the first patient package insert. 

Eideriy Clearance of ticlopidine is somewhat lower in elderly patients and trough levels are increased. No overall differences in safety or efficacy were observed between elderly patients and younger patients, but greater sensitivity of some older individuals cannot be ruled out. 

Safety was a concern and a formal rule was implemented (Bolland and Whitehead (2000)) with an overall one-sided type I error of 0.025 and 90 per cent power to detect an excess death rate in the ancrod group of 29 per cent compared to 18 per cent on placebo. This sequential plan was updated following the recruitment of every 20 patients. 

---